treatment dermatomyos intraven gammaglobulin purpos mainstay pharmacolog therapi patient dermatomyos corticosteroid patient refractori drug drug potenti short- long-term toxic altern therapi desir pilot studi high-dos intraven gammaglobulin ivgg treatment dermatomyos patient method ivgg patient juvenil dermatomyos prior ivgg treatment patient persist muscl weak daili corticosteroid patient unaccept steroid toxic patient toxic immunosuppress therapi result ivgg therapi improv muscl strength skin rash patient percentag increas muscl strength sphygmomanometri cours ivgg proxim extrem proxim upper extrem ivgg therapi prednison dose patient conclus studi ivgg steroid dermatomyos safe altern therapi 